ArchiMed

2 deals covered

1 platform

1 add-on

Most recent deal Tuesday, July 14, 2026.

Tuesday, July 14

1 deal

ArchiMed takes Esperion Therapeutics private for $1.1bn

The take-private adds a commercial-stage biopharma platform to ArchiMed, anchored by therapies for cardiometabolic and rare/orphan diseases, including lipid-lowering treatments.

Target: Esperion Therapeutics
Sponsor: ArchiMed
Source: PE Hub

Tuesday, June 9

1 deal

Add-onHealthcare

Archimed adds Barcelona PET radiopharmaceuticals maker IRAB

Based in Barcelona, the 2016-founded company produces PET radiopharmaceuticals used in clinical diagnosis, clinical trials and biomedical research.

Target: IRAB
Backed by: Archimed
Source: PE Hub